ZFNs and TALENs have the same basic form: a string of engineered proteins that recognize a sequence of bases (red) attached to FokI, which cuts the adjacent DNA.
Cas9
A tool developed in 2012 uses Cas9 as its DNA-cutting enzyme. Cas9 is nearly 2.5 times bigger than FokI.
POPULA ITY
The newest of the three main gene-editing tools, CRISPR-Cas9, has spread far and wide. Massachusetts-based Addgene, a non-pro t plasmid repository that distributes CRISPR-Cas9 editing kits to 83 countries, sends the largest proportion of its kits to US researchers. Non-homologous end joining for gene knock out DNA is repaired in an error-prone manner -by either adding or removing bases -so that the gene can no longer be translated.
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Homology-directed repair for gene knock in
A DNA template, or 'homologous sequence', accompanies the DNA-cutting enzyme so that the repair results in an altered or an inserted gene.
Countries are grappling with how to appropriately regulate human germline editing. As of December, before a Washington DC meeting organized by UK, US and Chinese scienti c societies, at least 29 countries have banned germline modi cation.
LEGAL STATUS LEGAL STATUS DOUBLE-ST ANDED B EAK DOUBLE-ST ANDED B EAK
All three of the main genome-editing tools (ZFNs, TALENs and CRISPR-Cas9) create a break across both strands of DNA at a speci c location, which is repaired in one of two ways to either 'knock out' or 'knock in' a gene. ARGENTINA has a 1997 law that bans human cloning, but no legislation that regulates human germline editing or other assisted reproductive technologies.
CHINA has guidelines prohibiting any manipulation of human eggs, sperm or embryos for reproductive purposes, but has not banned human germline modification in research.
THE UNITED KINGDOM has a strict ban on using embryos, sperm or eggs that have nuclear or mitochondrial DNA modification for reproductive purposes. Regulators may permit germline editing for research.
